3/25
02:31 pm
cnsp
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) had its "hold" rating re-affirmed by analysts at Maxim Group.
High
Report
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) had its "hold" rating re-affirmed by analysts at Maxim Group.
2/19
09:24 am
cnsp
CNS Pharmaceuticals to implement 1-for-50 reverse stock split [Seeking Alpha]
High
Report
CNS Pharmaceuticals to implement 1-for-50 reverse stock split [Seeking Alpha]
1/28
05:57 am
cnsp
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) was upgraded by analysts at Alliance Global Partners to a "strong-buy" rating.
Medium
Report
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) was upgraded by analysts at Alliance Global Partners to a "strong-buy" rating.